Network Pharmacology Strategy to Investigate the Pharmacological Mechanism of HuangQiXiXin Decoction on Cough Variant Asthma and Evidence-Based Medicine Approach Validation

Table 5

Summary of RCTs investigating HQXXD in CVA.

Study year [ref]	Country	Sample size (experimental/control)	Mean age (years) (experimental/control)	Experimental	Control
Wang and Xie 2009 [20]	China	42 (21/21)	34.5 ± 2.7/33.2 ± 2.6	HQXXD	Terbutaline tablet
Fan and Xie 2014 [19]	China	30 (30/30)	42.10 ± 8.27/38.2 ± 10.35	HQXXD	Procaterol hydrochloride tablet and albuterol aerosol
Li 2015 [17]	China	70 (35/35)	50 ± 1.5/49 ± 1.3	HQXXD	Procaterol hydrochloride tablet and albuterol aerosol
Wang and Xie 2015 [18]	China	90 (45/45)	41.12 ± 7.14/40.18 ± 9.35	HQXXD	Procaterol hydrochloride tablet
Wei and Qin 2019 [16]	China	80 (40/40)	45.35 ± 3.88/43.25 ± 3.78	HQXXD	Ambroxol hydrochloride tablet and terbutaline sulfate tablet